⟵ Back to Search Results

BGB-A317-fruquintinib-201

Recruiting

Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors

Beigene Study ID info

BGB-A317-fruquintinib-201

ClinicalTrials.gov ID info

NCT04716634

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents